Cmax and AUC are the two key metrics used globally to prove generic drugs work the same as brand-name versions. Cmax measures peak concentration, while AUC measures total exposure-both must fall within 80-125% of the original to ensure safety and effectiveness.
Learn how insurance companies, state laws, and pharmacy policies control generic drug substitution-and how to protect your right to the right medication. Real-world rules, patient stories, and step-by-step guidance.
Explains how the FDA uses dissolution testing to guarantee generic drugs meet quality standards, covering regulatory requirements, BCS classes, and real-world implementation.
Generic drugs are categorized by therapeutic use, mechanism of action, legal status, and insurance tiers. Understanding these classifications helps you make smarter choices about your prescriptions, costs, and safety.
Mandatory substitution laws force institutions to replace risky, harmful, or outdated elements with safer alternatives. Across finance, mental health, and environmental regulation, countries take wildly different approaches-and the consequences are real.
Hospital formularies use evidence-based criteria to choose generic drugs that balance safety, effectiveness, and cost. Learn how P&T committees make these decisions-and why they matter for patient care.
Learn how generic drug names like USAN and INN are created to prevent medication errors, why some drugs have different names in different countries, and how stems help doctors identify drug classes instantly.
Indemnification clauses protect businesses from financial risk in contracts. Learn how liability works, what triggers indemnity, and how to negotiate fair terms in any commercial deal.
